Ovarian Cancer Research Alliance Opportunities - LOI required

Sponsor Deadline: 

Jun 7, 2023

Letter of Intent Deadline: 

Mar 29, 2023

Sponsor: 

Ovarian Cancer Research Alliance OCRA

UI Contact: 

Sponsor link https://ocrahope.org/research/for-researchers/apply/

Opportunities include

  • Collaborative Research Development Grant - The purpose of this grantmaking program is to provide funds for ovarian cancer and/or related gynecologic cancers research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Interdisciplinary collaborations are encouraged.
  • Collaborative Research Development Grant – AI - For this opportunity, OCRA is partnering with Microsoft AI for Health, a philanthropic program at Microsoft, which offers access to advanced Microsoft Azure cloud computing and collaboration with data science experts for nonprofits, academia, and researchers working on challenges in the area of health, including ovarian cancer. Investigators funded through this grant opportunity have access to support from Microsoft in the form of Azure computing credits, and in-kind data science support. This in-kind support from Microsoft will be in addition to the financial support from OCRA. For more information, follow this link: https://www.microsoft.com/en-us/ai/ai-for-health. For FAQs regarding this partnership between Microsoft and OCRA, please look under the Collaborative Research Development Grant section of the FAQs found here: https://ocrahope.org/research/for-grantees/grant-applicationfaq/.
  • Mentored Investigator Grant - This grant provides funding for trainees who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research, or relevant area.
  • Early Career Investigator Grant - The Early Career Investigator Grant (ECIG) is for junior faculty with a strong commitment to an investigative career in the field of ovarian cancer research. The intent of these grants is to support a substantial time commitment to research and academic endeavors in ovarian cancer.

Categories: